MFS
SUPN icon

MSI Financial Services’s Supernus Pharmaceuticals SUPN Stock Holding History

MSI Financial Services’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$38K Hold
1,500
– – ﹤0.01% 2041
2016
Q3 		$37K Hold
1,500
– – ﹤0.01% 2009
2016
Q2 		$31K Buy
+1,500
New +$26.6K ﹤0.01% 2102

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MSI Financial Services's SUPN Position: Q4 2016 in Review

MSI Financial Services held its Supernus Pharmaceuticals (SUPN) position steady in Q4 2016 at 1,500 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

MSI Financial Services first reported a position in SUPN in Q2 2016 and has held it in 3 quarters since. 234 funds tracked by Wall St. Rank hold SUPN as of Q4 2016.

  • MSI Financial Services held 1,500 shares of Supernus Pharmaceuticals worth $38K as of Q4 2016.
  • MSI Financial Services left its Supernus Pharmaceuticals share count unchanged in Q4 2016.
  • Supernus Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2041 holding.
  • MSI Financial Services first reported a position in Supernus Pharmaceuticals in Q2 2016 and has held it in 3 quarters since.
  • 234 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.